Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 471-477

  Schmitz, N ^a   Gratwohl, A ^b   Goldman, J M ^c,d  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Europe; Haematopoietic; Indications; Practice

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ALLOGRAFT; APLASIA; AUTOIMMUNITY; AUTOTRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLASSIFICATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; EUROPE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SICKLE CELL ANEMIA; SOLID TUMOR; STEM CELL TRANSPLANTATION; THALASSEMIA; THERAPY;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; EUROPE; HEMATOLOGIC DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; INFANT; MIDDLE AGED; NEOPLASMS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029919543     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
2. Rowe JM, Ciobanu N, Ascensao J et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. Ann Intern Med 1994; 120: 143-158.
3. Goldman JM. Peripheral blood stem cells for allografting (editorial). Blood 1995; 85: 1413-1415.
4. Gratwohl A, Hermans J, Baldomero H et al. Indications for haemopoietic precursor cell transplants in Europe. Br J Haematol 1996; 92: 35-43.
5. Link H, Schmitz N, Gratwohl A, Goldman JM. Standards for specialist units undertaking blood and marrow stem cell transplants - recommendations from the EBMT. Bone Marrow Transplant 1995; 16: 733-763.
6. Goldman JM for the WMDA Executive Committee. A special report - bone marrow transplants using volunteer donors -recommendations and requirements for a standardized practice throughout the world. Blood 1994; 84: 2833-2839.
7. Long GD, Blume KG. Allogeneic bone marrow transplantation for acute myeloid leukemia. In: Foreman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 607-617.
8. Appelbaum FR, Fisher LD, Thomas ED et al. Chemotherapy versus bone marrow transplantation for adults with acute non-lymphocytic leukemia: a five year follow-up. Blood 1988; 72: 179-184.
9. Reiffers J, Gaspard MH, Maraninchi D et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy for patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57-63.
10. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
11. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
12. Horowitz MM, Messerer D, Hoelzer D et al. Comparison of chemotherapy and bone marrow transplantation for adults with acute lymphoblastic leukaemia in first remission. Ann Intern Med 1991; 115: 13-18.
13. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
14. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
15. Thomas ED, Clift R. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861-864.
16. McGlave PB, Bartsch F, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.
17. Reiffers J, Goldman J, Meloni G et al. Autologous stem cell transplantation in chronic myelogenous leukaemia: a retro-spective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-410.
18. Rabinowe SN, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 83: 1366-1376.
19. Khouri IF, Keating MJ, Vriesendrop HM et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994; 12: 748-758.
20. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplants for chronic lymphocytic leukemia (CLL). A collaborative study of the EBMT and IBMTR. Ann Intern Med 1996; 124: 311-315.
21. Michallet M, Archimbaud E, Juliusson G et al. Autologous transplants in chronic lymphocytic leukemia: report of 18 cases. Abstracts of the 21st Annual Meeting of the EBMT, Davos, Switzerland, March 1995. p 15.
22. Philip T, Armitage JO. Spitzer G et al. High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. New Engl J Med 1987; 316: 1493-1498.
23. Philip T, Guglielmo C, Hagenbeek A et al The Parma international randomized prospective study in relapsed non-Hodgkin's lymphoma: first results of the final analysis. New Engl J Med 1995; 333: 1540-1545.
24. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051-1054.
25. Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma. New Engl J Med 1991; 325: 1267-1273.
26. Gahrton G, Tura S. Ljungman P et al. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 1995; 13: 1312-1322.
27. Bjorkstrand B, Goldstone AH, Ljungman P et al. Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT registry study. Leuk Lymphoma 1994; 15: 265-272.
28. Attal M, Harousseau JL, Stoppa AM et al. High dose therapy in multiple myeloma: a prospective randomized study of the 'Intergroupe Francais du Myelome (IFM)'. Presented at the 21st Annual Meeting of the EBMT, Davos, Switzerland, March 1995, Abstr. No. 71.
29. De Witte T. New treatment approaches for myelodysplastic syndrome and secondary acute leukaemias. Ann Oncol 1994; 5: 401-408.
30. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodys-plastic syndrome. Blood 1993; 82: 677-681.
31. Fischer A, Landais P, Friedrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994; 83: 1149-1154.
32. Gerritsen EJA, Vossen JM, Fasth A et al. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr 1994; 125: 896-902.
33. Fischer A, Landais P, Friedrich W et al. The European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 1990; 336: 850-854.
34. Krivit W, Shaprio EG. Bone marrow transplantation for storage diseases. In: Foreman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1993, pp 883-893.
35. Hoogerbrugge PM, Brouwer OF, Bordigoni P et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet 1995; 345: 1398-I402.
36. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia. New Engl J Med 1990; 322: 417-421.
37. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in adult thalassemia. Blood 1992; 80: 1603-1607.
38. Lucarelli G, Clift RA. Bone marrow transplantation in thalassemia. In: Foreman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, p 829.
39. Vermylen C, Cornu G, Philippe M et al. Bone marrow transplantation in sickle cell anaemia. Arch Dis Child 1991; 66: 1195-1198.
40. Vermylen C, Cornu G. Bone marrow transplantation in sickle cell anaemia. Blood Rev 1993; 7: 1-3.
41. Vermylen C, Cornu G. Bone marrow transplantation in sickle cell anemia: the European experience. Am J Ped Hematol/Oncol 1994; 16: 18-21.
42. Storb R, Etzioni R, Anasetti C et al. Cyctophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994; 84: 941-949.
43. Socie G, Henry-Amar M, Bacigalupo A et al. Malignant tumors occurring after treatment of aplastic anemia. New Engl J Med 1993; 329: 1152-1157.
44. Bacigalupo A for the Working Group on Severe Aplastic Anemia of the European Group for Bone Marrow Transplantation (EBMT): guidelines for the treatment of severe aplastic anemia. Haematologica 1994; 79: 438-444.
45. Marsh JCW, Socie G, Schrezenmeier H et al. Haemopoietic growth factors in aplastic anaemia: a cautionary note. Lancet 1994; 334: 172-173.
46. Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856-2862.
47. Droz JP, Pico P, Biron P et al. No evidence of a benefit of early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor-risk non-seminomatous germ cell tumors: preliminary results of a randomized trial. Proc ASCO 1992; 11: 197.
48. Philip T, Zucker JM, Bernard JL et al. Improved survival at 2 and 5 years in LMCE1 unselected group of 72 children with stage IV neuroblastoma over 1 year of age at diagnosis: is cure possible in a small sub-group? J Clin Oncol 1991: 9: 1037-1044.
49. Peters WP, Ross M, Vredenburgh JJ et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132-1143.
50. Marmont A. Immune ablation followed by allogeneic bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem Cells 1994; 12: 125-135.
51. Marmont AM, Tyndall A, Gratwohl A, Vischer T. Haematopoietic precursor cell transplants for autoimmune diseases. Lancet 1995; 345: 978.
52. Marmont AM, van Bekkum D. Haematopoietic stem cell transplantation for patients with auto-immune disorders. Bone Marrow Transplant 1995; 16: 497-498.